R&D Systems™ Recombinant Human S100A11 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human S100A11 Protein is derived from E. coli. The Recombinant Human S100A11 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P31949
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 6282
• Molecular Weight (g/mol): Observed M.W.: 9kDa, reducing conditions, Theoretical M.W.: 12kDa
• Quantity: 50μg
• Source: E. coli-derived human S100A11 protein Ala2-Thr105
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: calgizzarin, Metastatic lymph node gene 70 protein, MLN 70, MLN70, protein S100-A11, Protein S100-C, S100 calcium binding protein A11, S100 calcium-binding protein A11, S100 calcium-binding protein A11 (calgizzarin), S100C, S100CS100 calcium binding protein A11 (calgizzarin)
• Common Name: S100A11
• Gene Symbol: S100A11
• Biological Activity: Measured by its binding ability in a functional ELISA. When Recombinant Human ANXA-2 is immobilized at 0.5μg/mL (100μL/well), the concentration of Recombinant Human S100A11 that produces 50% of the optimal binding response is approximately 0.4-2.4μg/mL.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: E. coli-derived Ala2-Thr105
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining